Fracture risk is increased in epilepsy
Objectives ‐ To study fracture rates and risk factors for fractures in non‐institutionalized patients with epilepsy. Material and methods ‐ Historical follow‐up. Self‐administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to (340.9) and 1000 randomly selected controls f...
Saved in:
Published in | Acta neurologica Scandinavica Vol. 99; no. 5; pp. 269 - 275 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.05.1999
Blackwell |
Subjects | |
Online Access | Get full text |
ISSN | 0001-6314 1600-0404 |
DOI | 10.1111/j.1600-0404.1999.tb00675.x |
Cover
Abstract | Objectives ‐ To study fracture rates and risk factors for fractures in non‐institutionalized patients with epilepsy. Material and methods ‐ Historical follow‐up. Self‐administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to (340.9) and 1000 randomly selected controls from the background population. Results ‐ A total of 345 patients (median age: 45, range 17–80 years) and 654 control subjects (median age: 43. range 19–93 years) returned the questionnaire. Before epilepsy was diagnosed there was no difference in overall fracture rate between patients and controls (RR = 1.0, 95% CI: 0.8–1.3). After the diagnosis the overall fracture rate was significantly higher in the patients (RR = 2.0, 95% CI: 1.6–2.5). Fractures of the spine, forearms, femurs, lower legs, and feet and toes were significantly increased. Fractures related to seizures accounted for 33.9% (95% CI: 25.3–43.5%) of all fractures. After elimination of seizure related fractures the increase in fracture frequency was only borderline significant: RR = 1.3 (95% CI: 1.0–1.7, P = 0.042). No difference in fracture energy between patients and controls was observed (low energy fractures: 1.7/1.4%, medium energy fractures: 59.8/52.0%, and high energy fractures: 38.3/46.6%). Use of phenytoin (OR = 2.4, 95% CI: 1.1–5.4) and a family fracture history (OR = 2.4, 95% CI: 1.34.6) was associated with an increased fracture risk. Conclusions ‐ Fractures were more common in epileptics than in controls especially among users of phenytoin. Most of the increase in fracture frequency was related to seizures and not to low bone biomechanical competence. |
---|---|
AbstractList | To study fracture rates and risk factors for fractures in non-institutionalized patients with epilepsy.
Historical follow-up. Self-administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to G40.9) and 1000 randomly selected controls from the background population.
A total of 345 patients (median age: 45, range 17-80 years) and 654 control subjects (median age: 43, range 19-93 years) returned the questionnaire. Before epilepsy was diagnosed there was no difference in overall fracture rate between patients and controls (RR = 1.0, 95% CI: 0.8-1.3). After the diagnosis the overall fracture rate was significantly higher in the patients (RR = 2.0, 95% CI: 1.6-2.5). Fractures of the spine, forearms, femurs, lower legs, and feet and toes were significantly increased. Fractures related to seizures accounted for 33.9% (95% CI: 25.3-43.5%) of all fractures. After elimination of seizure related fractures the increase in fracture frequency was only borderline significant: RR = 1.3 (95% CI: 1.0-1.7, P = 0.042). No difference in fracture energy between patients and controls was observed (low energy fractures: 1.7/1.4%, medium energy fractures: 59.8/52.0%, and high energy fractures: 38.3/46.6%). Use of phenytoin (OR = 2.4, 95% CI: 1.1-5.4) and a family fracture history (OR = 2.4, 95% CI: 1.3-4.6) was associated with an increased fracture risk.
Fractures were more common in epileptics than in controls especially among users of phenytoin. Most of the increase in fracture frequency was related to seizures and not to low bone biomechanical competence. Objectives ‐ To study fracture rates and risk factors for fractures in non‐institutionalized patients with epilepsy. Material and methods ‐ Historical follow‐up. Self‐administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to (340.9) and 1000 randomly selected controls from the background population. Results ‐ A total of 345 patients (median age: 45, range 17–80 years) and 654 control subjects (median age: 43. range 19–93 years) returned the questionnaire. Before epilepsy was diagnosed there was no difference in overall fracture rate between patients and controls (RR = 1.0, 95% CI: 0.8–1.3). After the diagnosis the overall fracture rate was significantly higher in the patients (RR = 2.0, 95% CI: 1.6–2.5). Fractures of the spine, forearms, femurs, lower legs, and feet and toes were significantly increased. Fractures related to seizures accounted for 33.9% (95% CI: 25.3–43.5%) of all fractures. After elimination of seizure related fractures the increase in fracture frequency was only borderline significant: RR = 1.3 (95% CI: 1.0–1.7, P = 0.042). No difference in fracture energy between patients and controls was observed (low energy fractures: 1.7/1.4%, medium energy fractures: 59.8/52.0%, and high energy fractures: 38.3/46.6%). Use of phenytoin (OR = 2.4, 95% CI: 1.1–5.4) and a family fracture history (OR = 2.4, 95% CI: 1.34.6) was associated with an increased fracture risk. Conclusions ‐ Fractures were more common in epileptics than in controls especially among users of phenytoin. Most of the increase in fracture frequency was related to seizures and not to low bone biomechanical competence. To study fracture rates and risk factors for fractures in non-institutionalized patients with epilepsy.OBJECTIVESTo study fracture rates and risk factors for fractures in non-institutionalized patients with epilepsy.Historical follow-up. Self-administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to G40.9) and 1000 randomly selected controls from the background population.MATERIAL AND METHODSHistorical follow-up. Self-administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to G40.9) and 1000 randomly selected controls from the background population.A total of 345 patients (median age: 45, range 17-80 years) and 654 control subjects (median age: 43, range 19-93 years) returned the questionnaire. Before epilepsy was diagnosed there was no difference in overall fracture rate between patients and controls (RR = 1.0, 95% CI: 0.8-1.3). After the diagnosis the overall fracture rate was significantly higher in the patients (RR = 2.0, 95% CI: 1.6-2.5). Fractures of the spine, forearms, femurs, lower legs, and feet and toes were significantly increased. Fractures related to seizures accounted for 33.9% (95% CI: 25.3-43.5%) of all fractures. After elimination of seizure related fractures the increase in fracture frequency was only borderline significant: RR = 1.3 (95% CI: 1.0-1.7, P = 0.042). No difference in fracture energy between patients and controls was observed (low energy fractures: 1.7/1.4%, medium energy fractures: 59.8/52.0%, and high energy fractures: 38.3/46.6%). Use of phenytoin (OR = 2.4, 95% CI: 1.1-5.4) and a family fracture history (OR = 2.4, 95% CI: 1.3-4.6) was associated with an increased fracture risk.RESULTSA total of 345 patients (median age: 45, range 17-80 years) and 654 control subjects (median age: 43, range 19-93 years) returned the questionnaire. Before epilepsy was diagnosed there was no difference in overall fracture rate between patients and controls (RR = 1.0, 95% CI: 0.8-1.3). After the diagnosis the overall fracture rate was significantly higher in the patients (RR = 2.0, 95% CI: 1.6-2.5). Fractures of the spine, forearms, femurs, lower legs, and feet and toes were significantly increased. Fractures related to seizures accounted for 33.9% (95% CI: 25.3-43.5%) of all fractures. After elimination of seizure related fractures the increase in fracture frequency was only borderline significant: RR = 1.3 (95% CI: 1.0-1.7, P = 0.042). No difference in fracture energy between patients and controls was observed (low energy fractures: 1.7/1.4%, medium energy fractures: 59.8/52.0%, and high energy fractures: 38.3/46.6%). Use of phenytoin (OR = 2.4, 95% CI: 1.1-5.4) and a family fracture history (OR = 2.4, 95% CI: 1.3-4.6) was associated with an increased fracture risk.Fractures were more common in epileptics than in controls especially among users of phenytoin. Most of the increase in fracture frequency was related to seizures and not to low bone biomechanical competence.CONCLUSIONSFractures were more common in epileptics than in controls especially among users of phenytoin. Most of the increase in fracture frequency was related to seizures and not to low bone biomechanical competence. |
Author | Vestergaard, P. Tigaran, S. Tigaran, C. Rejnmark, L. Mosekilde, L. Dam, M. |
Author_xml | – sequence: 1 givenname: P. surname: Vestergaard fullname: Vestergaard, P. – sequence: 2 givenname: S. surname: Tigaran fullname: Tigaran, S. – sequence: 3 givenname: L. surname: Rejnmark fullname: Rejnmark, L. – sequence: 4 givenname: C. surname: Tigaran fullname: Tigaran, C. – sequence: 5 givenname: M. surname: Dam fullname: Dam, M. – sequence: 6 givenname: L. surname: Mosekilde fullname: Mosekilde, L. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1775106$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10348155$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkFtLwzAYhoNM3EH_ggwR71qTNYfGC3GMTYWhN3od0vQrZHbtTDrc_r2pmw680twkIc_38ubpo05VV4DQBcExCet6EROOcYQppjGRUsZNhjEXLN4cod7PUwf1MMYk4gmhXdT3fhFuI0HpCeoSnNCUMNZDVzOnTbN2MHTWvw2tH9rKONAe8nAawsqWsPLbU3Rc6NLD2X4foNfZ9GXyEM2f7x8n43lkklAkApIBEVnKZSK1kawQoxyKnBY8TzFLGB0JIyTVUuZMCK5T4CmDrEih4JrleTIIhb5yV65-X4Nv1NJ6A2WpK6jXXnEpUk4TEcDzPbjOlpCrlbNL7bbq-2cBuNwD2htdFk5XxvoDJwQjmAfsbocZV3vvoFDGNrqxddU4bcuQp1rnaqFasaoVq1rnau9cbULEza-IQ5k_DN_uhj-C6O0_JtX4aToKnj8Bt8-ZKA |
CODEN | ANRSAS |
CitedBy_id | crossref_primary_10_1016_j_yebeh_2003_11_030 crossref_primary_10_1016_j_rbo_2017_01_012 crossref_primary_10_1111_epi_12351 crossref_primary_10_1016_j_bone_2023_116784 crossref_primary_10_1016_j_eplepsyres_2012_09_002 crossref_primary_10_1097_01_nrl_0000087719_64343_be crossref_primary_10_1016_j_rhum_2007_01_024 crossref_primary_10_5937_mp75_51140 crossref_primary_10_1016_j_bbapap_2010_05_014 crossref_primary_10_1016_j_drudis_2009_01_004 crossref_primary_10_1111_epi_16678 crossref_primary_10_1016_j_yebeh_2013_12_021 crossref_primary_10_1186_s41983_018_0014_2 crossref_primary_10_1186_s13018_020_02151_1 crossref_primary_10_1016_j_jclinepi_2011_09_004 crossref_primary_10_1203_PDR_0b013e31820bc6d3 crossref_primary_10_1046_j_1528_1157_2002_15801_x crossref_primary_10_1590_S0004_282X2004000600003 crossref_primary_10_1007_s00402_022_04420_6 crossref_primary_10_1517_14740338_2011_534455 crossref_primary_10_1111_j_1528_1167_2009_02170_x crossref_primary_10_1007_s13670_014_0078_5 crossref_primary_10_1007_s00198_008_0711_2 crossref_primary_10_1016_j_clineuro_2007_07_002 crossref_primary_10_1212_01_WNL_0000142991_14507_B5 crossref_primary_10_1046_j_1528_1157_2002_18701_x crossref_primary_10_1016_j_yebeh_2019_106651 crossref_primary_10_1111_epi_16700 crossref_primary_10_1186_1471_2431_13_211 crossref_primary_10_1007_s10049_020_00784_7 crossref_primary_10_1212_WNL_63_10_suppl_4_S24 crossref_primary_10_1111_j_0013_9580_2005_23804_x crossref_primary_10_1093_ageing_afs178 crossref_primary_10_4061_2010_808341 crossref_primary_10_1016_j_yebeh_2004_02_005 crossref_primary_10_1016_j_jbspin_2019_11_003 crossref_primary_10_1016_j_arth_2022_08_022 crossref_primary_10_1046_j_1535_7597_2003_03306_x crossref_primary_10_1111_j_0013_9580_2004_18804_x crossref_primary_10_1186_1743_7075_3_36 crossref_primary_10_1177_1759720X13475851 crossref_primary_10_1111_j_1528_1167_2006_00666_x crossref_primary_10_1007_s00115_004_1803_7 crossref_primary_10_1016_S0090_3019_02_00837_6 crossref_primary_10_2165_00002018_200730020_00006 crossref_primary_10_1212_01_WNL_0000125185_74276_D2 crossref_primary_10_5694_j_1326_5377_2005_tb07001_x crossref_primary_10_17749_2077_8333_epi_par_con_2022_117 crossref_primary_10_1007_s11910_013_0361_4 crossref_primary_10_1111_j_0013_9580_2004_33803_x crossref_primary_10_1016_j_yebeh_2019_106511 crossref_primary_10_1007_s10309_005_0141_5 crossref_primary_10_1016_j_yebeh_2006_08_003 crossref_primary_10_1016_j_seizure_2020_10_003 crossref_primary_10_1016_j_eplepsyres_2004_05_004 crossref_primary_10_1111_j_1528_1167_2007_01499_x crossref_primary_10_1111_j_1600_0404_2005_00474_x crossref_primary_10_1517_14740338_6_3_251 crossref_primary_10_1093_jamia_ocv061 crossref_primary_10_1007_s00774_023_01475_2 crossref_primary_10_1530_EJE_15_0118 crossref_primary_10_1016_j_jse_2023_09_023 crossref_primary_10_1161_circ_102_suppl_1_I_77 crossref_primary_10_1016_j_neuchi_2021_04_004 crossref_primary_10_1186_s13690_020_00405_2 crossref_primary_10_1016_S8756_3282_02_00788_3 crossref_primary_10_3389_fneur_2014_00142 crossref_primary_10_4065_82_1_40 crossref_primary_10_1016_j_jbspin_2007_01_039 crossref_primary_10_1007_s11940_008_0026_9 crossref_primary_10_1186_1757_1626_3_30 crossref_primary_10_1016_j_annemergmed_2005_03_009 crossref_primary_10_1016_j_rboe_2017_03_009 crossref_primary_10_1007_s11910_004_0060_2 crossref_primary_10_1016_j_monrhu_2011_01_002 crossref_primary_10_1007_s00198_013_2446_y crossref_primary_10_1016_j_eplepsyres_2005_07_016 crossref_primary_10_1016_j_jns_2013_05_005 crossref_primary_10_1359_jbmr_2003_18_5_900 crossref_primary_10_1007_s11914_016_0302_7 crossref_primary_10_1111_epi_14738 crossref_primary_10_1016_j_seizure_2012_10_002 crossref_primary_10_1212_WNL_61_6_suppl_2_S16 crossref_primary_10_1080_14740338_2018_1524868 crossref_primary_10_1016_j_rhum_2020_01_035 crossref_primary_10_1111_epi_16465 crossref_primary_10_1111_j_1528_1167_2008_01640_x crossref_primary_10_4065_76_2_175 crossref_primary_10_1007_s00125_005_1786_3 crossref_primary_10_1212_01_CON_0000368237_49610_93 crossref_primary_10_1016_j_spen_2017_10_005 crossref_primary_10_1111_j_1528_1167_2006_00803_x crossref_primary_10_1007_s11940_015_0342_9 crossref_primary_10_1590_S1676_26492010000200007 crossref_primary_10_1007_s11282_023_00671_0 crossref_primary_10_1007_s00198_006_0185_z crossref_primary_10_1016_j_bone_2014_04_018 crossref_primary_10_1016_S0025_6196_11_63125_X crossref_primary_10_1002_epi4_12776 crossref_primary_10_1016_j_amjopharm_2010_02_003 crossref_primary_10_1016_S1474_4422_04_00935_4 crossref_primary_10_1007_s43440_020_00087_1 crossref_primary_10_1016_S0300_9572_00_00273_2 crossref_primary_10_1111_j_1365_2796_2005_01467_x crossref_primary_10_1007_s00223_012_9603_8 crossref_primary_10_1016_j_ijep_2017_04_001 crossref_primary_10_1155_2015_646352 crossref_primary_10_1007_s00198_005_1892_6 crossref_primary_10_3389_fpsyt_2023_1208887 crossref_primary_10_1016_j_spen_2007_08_006 crossref_primary_10_1177_1759720X14546350 crossref_primary_10_1016_S0920_1211_00_00126_1 crossref_primary_10_1016_j_clineuro_2011_03_011 crossref_primary_10_1542_peds_2013_2554 crossref_primary_10_1016_j_eplepsyres_2020_106461 crossref_primary_10_1016_j_jamda_2022_06_001 crossref_primary_10_2217_ahe_09_88 crossref_primary_10_2165_00023210_200115080_00006 crossref_primary_10_1016_S0025_6196_11_60965_8 crossref_primary_10_1111_j_1532_5415_2007_01081_x crossref_primary_10_1080_09674845_2019_1663781 crossref_primary_10_1016_j_pjnns_2015_06_007 crossref_primary_10_1016_S1525_5050_03_00036_2 crossref_primary_10_1111_j_1528_1167_2009_02254_x crossref_primary_10_2217_14750708_4_1_79 crossref_primary_10_1016_j_berh_2022_101755 crossref_primary_10_1586_14737175_9_2_291 crossref_primary_10_1111_j_0013_9580_2004_33903_x crossref_primary_10_1212_WNL_0000000000003629 crossref_primary_10_1007_s00223_008_9124_7 crossref_primary_10_1210_jc_2013_4275 crossref_primary_10_1016_j_yebeh_2003_11_027 crossref_primary_10_1016_j_yebeh_2003_11_026 crossref_primary_10_1136_bcr_2019_230143 crossref_primary_10_1016_j_yebeh_2003_11_029 crossref_primary_10_1016_j_yebeh_2003_11_028 crossref_primary_10_55095_achot2007_032 crossref_primary_10_2522_ptj_20100383 crossref_primary_10_1007_s11926_008_0019_4 |
Cites_doi | 10.1111/j.1528-1157.1993.tb02099.x 10.1016/0221-8747(80)90001-6 10.1001/archneur.1996.00550090141020 10.1056/NEJM199503233321202 10.1016/1047-2797(94)00100-8 10.1111/j.1528-1157.1997.tb01733.x 10.1016/0020-1383(95)00189-1 10.1056/NEJM199212033272305 10.1111/j.0954-6820.1979.tb06073.x 10.1111/j.1528-1157.1995.tb01660.x 10.1038/sj.sc.3100648 10.3109/17453677708992008 10.1172/JCI109142 10.1007/BF00433931 10.1016/0735-6757(95)90213-9 10.1002/jbmr.5650110920 10.1111/j.0954-6820.1979.tb06072.x 10.7326/0003-4819-77-3-389 |
ContentType | Journal Article |
Copyright | 1999 Blackwell Munksgaard 1999 INIST-CNRS |
Copyright_xml | – notice: 1999 Blackwell Munksgaard – notice: 1999 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/j.1600-0404.1999.tb00675.x |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1600-0404 |
EndPage | 275 |
ExternalDocumentID | 10348155 1775106 10_1111_j_1600_0404_1999_tb00675_x ANE269 |
Genre | caseStudy Clinical Trial Randomized Controlled Trial Journal Article |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAHHS AAJEY AAKAS AANHP AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABIVO ABJNI ABLJU ABPVW ABUWG ABXGK ACAHQ ACBWZ ACCFJ ACCMX ACCZN ACGFS ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFFNX AFGKR AFKRA AFPWT AFZJQ AHEFC AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM EAD EAP EAS EBC EBD EBS EJD EMB EMK EMOBN EPS ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FYBCS FYUFA FZ0 G-S G.N GODZA H.X H13 HF~ HMCUK HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PIMPY PQQKQ Q.N Q11 QB0 R.K RHX RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 UKHRP W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH ZGI ZXP ZZTAW ~IA ~WT AAYXX AGQPQ CITATION PHGZM PHGZT AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM PKN 7X8 |
ID | FETCH-LOGICAL-c3999-e1be17b86939ac95f72defd4f6d80535427c794a99d5776a8e685ebf8ef6a5dd3 |
IEDL.DBID | DR2 |
ISSN | 0001-6314 |
IngestDate | Fri Sep 05 06:38:40 EDT 2025 Wed Feb 19 02:32:33 EST 2025 Mon Jul 21 09:13:49 EDT 2025 Tue Jul 01 00:38:46 EDT 2025 Thu Apr 24 23:02:26 EDT 2025 Wed Jan 22 17:07:27 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Human Nervous system diseases Epilepsy Diseases of the osteoarticular system Anticonvulsant Fracture Trauma Cerebral disorder Chemotherapy Type Central nervous system disease Risk factor Adult Complication Frequency Bone |
Language | English |
License | http://doi.wiley.com/10.1002/tdm_license_1.1 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3999-e1be17b86939ac95f72defd4f6d80535427c794a99d5776a8e685ebf8ef6a5dd3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
PMID | 10348155 |
PQID | 69786437 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_69786437 pubmed_primary_10348155 pascalfrancis_primary_1775106 crossref_citationtrail_10_1111_j_1600_0404_1999_tb00675_x crossref_primary_10_1111_j_1600_0404_1999_tb00675_x wiley_primary_10_1111_j_1600_0404_1999_tb00675_x_ANE269 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | May 1999 |
PublicationDateYYYYMMDD | 1999-05-01 |
PublicationDate_xml | – month: 05 year: 1999 text: May 1999 |
PublicationDecade | 1990 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: Denmark |
PublicationTitle | Acta neurologica Scandinavica |
PublicationTitleAlternate | Acta Neurol Scand |
PublicationYear | 1999 |
Publisher | Blackwell Publishing Ltd Blackwell |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
References | 1993; 34 1986; 105 1977; 48 1995; 36 1997; 52 1980; 2 1995; 13 1979; 205 1978; 62 1992; 327 1997; 38 1994 1995; 332 1996; 27 1972; 77 1995; 5 1996; 53 1998; 36 1996; 11 Lidgren (10.1111/j.1600-0404.1999.tb00675.x-BIB1) 1977; 48 Sotaniemi (10.1111/j.1600-0404.1999.tb00675.x-BIB14) 1972; 77 Kirby (10.1111/j.1600-0404.1999.tb00675.x-BIB7) 1995; 36 Wirrell (10.1111/j.1600-0404.1999.tb00675.x-BIB8) 1996; 53 Chapuy (10.1111/j.1600-0404.1999.tb00675.x-BIB16) 1992; 327 Seeley (10.1111/j.1600-0404.1999.tb00675.x-BIB5) 1996; 11 Buck (10.1111/j.1600-0404.1999.tb00675.x-BIB6) 1997; 38 Vestercaard (10.1111/j.1600-0404.1999.tb00675.x-BIB19) 1998; 36 Jaclal (10.1111/j.1600-0404.1999.tb00675.x-BIB4) 1995; 5 Dymlinc (10.1111/j.1600-0404.1999.tb00675.x-BIB11) 1979; 205 Cummings (10.1111/j.1600-0404.1999.tb00675.x-BIB3) 1995; 332 Mosekilde (10.1111/j.1600-0404.1999.tb00675.x-BIB10) 1979; 205 Mosekilde (10.1111/j.1600-0404.1999.tb00675.x-BIB13) 1980; 2 10.1111/j.1600-0404.1999.tb00675.x-BIB15 Hahn (10.1111/j.1600-0404.1999.tb00675.x-BIB18) 1978; 62 Nilsson (10.1111/j.1600-0404.1999.tb00675.x-BIB12) 1986; 105 Desai (10.1111/j.1600-0404.1999.tb00675.x-BIB2) 1996; 27 Cohen (10.1111/j.1600-0404.1999.tb00675.x-BIB17) 1997; 52 Elbercer (10.1111/j.1600-0404.1999.tb00675.x-BIB20) 1995; 13 Nakken (10.1111/j.1600-0404.1999.tb00675.x-BIB9) 1993; 34 |
References_xml | – volume: 36 start-page: 25 year: 1995 end-page: 8 article-title: Injury and death as a result of seizures publication-title: Epilepsia – volume: 205 start-page: 405 year: 1979 end-page: 9 article-title: Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy: short term effects of 1,25‐dihydroxycholecal‐ciferol and 25‐hydroxycholecalciferol publication-title: Acta Med Scand – volume: 27 start-page: 97 year: 1996 end-page: 100 article-title: Incidence of five common fracture types in an institutional epileptic population publication-title: Injury – volume: 11 start-page: 1347 year: 1996 end-page: 55 article-title: Predictors of ankle and foot fractures in older women. The Study of Osteoporotic Fractures Research Group publication-title: J Bone Miner Res – volume: 77 start-page: 389 year: 1972 end-page: 94 article-title: Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy publication-title: Ann Intern Med – volume: 13 start-page: 331 year: 1995 end-page: 2 article-title: Bilateral posterior shoulder dislocations publication-title: Am J Emerg Med – volume: 34 start-page: 836 year: 1993 end-page: 40 article-title: Seizure‐related injuries in multi‐handicapped patients with therapy‐resistant epilepsy publication-title: Epilepsia – volume: 38 start-page: 439 year: 1997 end-page: 44 article-title: Patients' experiences of injury as a result of epilepsy publication-title: Epilepsia – volume: 36 start-page: 790 year: 1998 end-page: 6 article-title: Fracture rates and risk factors for fractures in patients with spinal cord injury publication-title: Spinal Cord – volume: 332 start-page: 767 year: 1995 end-page: 73 article-title: Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group publication-title: N Engl J Med – volume: 62 start-page: 406 year: 1978 end-page: 14 article-title: Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal medication of fetal rat bone resorption in vitro publication-title: J Clin Invest – volume: 48 start-page: 356 year: 1977 end-page: 61 article-title: Incidence of fracture in epileptics publication-title: Acta Orthop Scand – volume: 2 start-page: 77 year: 1980 end-page: 82 article-title: Dynamic differences in trabecular bone remodeling between patients after jejunoileal bypass for obesity and epileptic patients receiving anticonvulsant therapy publication-title: Metab Bone Dis & Rel Res – volume: 52 start-page: 70,75 year: 1997 end-page: 8,81 article-title: Strategies to protect bone mass in the older patient with epilepsy publication-title: Geriatrics – volume: 205 start-page: 401 year: 1979 end-page: 4 article-title: Biochemical variables related to calcium metabolism in epileptics publication-title: Acta Med Scand – volume: 53 start-page: 929 year: 1996 end-page: 32 article-title: Accidental injury is a serious risk in children with typical absence epilepsy publication-title: Arch Neurol – volume: 327 start-page: 1637 year: 1992 end-page: 42 article-title: Vitamin D, and calcium to prevent hip fractures in elderly women publication-title: N Engl J Med – volume: 5 start-page: 321 year: 1995 end-page: 4 article-title: Lifetime occupational physical activity and risk of hip fracture in women publication-title: Ann Epidemiol – volume: 105 start-page: 146 year: 1986 end-page: 9 article-title: Fracture incidence and bone disease in epileptics receiving long‐term anticonvulsant drug treatment publication-title: Arch Orthop Trauma Surg – year: 1994 – volume: 34 start-page: 836 year: 1993 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB9 article-title: Seizure-related injuries in multi-handicapped patients with therapy-resistant epilepsy publication-title: Epilepsia doi: 10.1111/j.1528-1157.1993.tb02099.x – volume: 2 start-page: 77 year: 1980 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB13 article-title: Dynamic differences in trabecular bone remodeling between patients after jejunoileal bypass for obesity and epileptic patients receiving anticonvulsant therapy publication-title: Metab Bone Dis & Rel Res doi: 10.1016/0221-8747(80)90001-6 – volume: 53 start-page: 929 year: 1996 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB8 article-title: Accidental injury is a serious risk in children with typical absence epilepsy publication-title: Arch Neurol doi: 10.1001/archneur.1996.00550090141020 – volume: 332 start-page: 767 year: 1995 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB3 article-title: Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group publication-title: N Engl J Med doi: 10.1056/NEJM199503233321202 – volume: 5 start-page: 321 year: 1995 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB4 article-title: Lifetime occupational physical activity and risk of hip fracture in women publication-title: Ann Epidemiol doi: 10.1016/1047-2797(94)00100-8 – volume: 38 start-page: 439 year: 1997 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB6 article-title: Patients' experiences of injury as a result of epilepsy publication-title: Epilepsia doi: 10.1111/j.1528-1157.1997.tb01733.x – ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB15 – volume: 27 start-page: 97 year: 1996 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB2 article-title: Incidence of five common fracture types in an institutional epileptic population publication-title: Injury doi: 10.1016/0020-1383(95)00189-1 – volume: 327 start-page: 1637 year: 1992 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB16 article-title: Vitamin D, and calcium to prevent hip fractures in elderly women publication-title: N Engl J Med doi: 10.1056/NEJM199212033272305 – volume: 205 start-page: 405 year: 1979 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB10 article-title: Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy: short term effects of 1,25-dihydroxycholecal-ciferol and 25-hydroxycholecalciferol publication-title: Acta Med Scand doi: 10.1111/j.0954-6820.1979.tb06073.x – volume: 36 start-page: 25 year: 1995 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB7 article-title: Injury and death as a result of seizures publication-title: Epilepsia doi: 10.1111/j.1528-1157.1995.tb01660.x – volume: 52 start-page: 70,75 year: 1997 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB17 article-title: Strategies to protect bone mass in the older patient with epilepsy publication-title: Geriatrics – volume: 36 start-page: 790 year: 1998 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB19 article-title: Fracture rates and risk factors for fractures in patients with spinal cord injury publication-title: Spinal Cord doi: 10.1038/sj.sc.3100648 – volume: 48 start-page: 356 year: 1977 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB1 article-title: Incidence of fracture in epileptics publication-title: Acta Orthop Scand doi: 10.3109/17453677708992008 – volume: 62 start-page: 406 year: 1978 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB18 article-title: Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal medication of fetal rat bone resorption in vitro publication-title: J Clin Invest doi: 10.1172/JCI109142 – volume: 105 start-page: 146 year: 1986 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB12 article-title: Fracture incidence and bone disease in epileptics receiving long-term anticonvulsant drug treatment publication-title: Arch Orthop Trauma Surg doi: 10.1007/BF00433931 – volume: 13 start-page: 331 year: 1995 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB20 article-title: Bilateral posterior shoulder dislocations publication-title: Am J Emerg Med doi: 10.1016/0735-6757(95)90213-9 – volume: 11 start-page: 1347 year: 1996 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB5 article-title: Predictors of ankle and foot fractures in older women. The Study of Osteoporotic Fractures Research Group publication-title: J Bone Miner Res doi: 10.1002/jbmr.5650110920 – volume: 205 start-page: 401 year: 1979 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB11 article-title: Biochemical variables related to calcium metabolism in epileptics publication-title: Acta Med Scand doi: 10.1111/j.0954-6820.1979.tb06072.x – volume: 77 start-page: 389 year: 1972 ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB14 article-title: Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy publication-title: Ann Intern Med doi: 10.7326/0003-4819-77-3-389 |
SSID | ssj0012744 |
Score | 1.9534687 |
Snippet | Objectives ‐ To study fracture rates and risk factors for fractures in non‐institutionalized patients with epilepsy. Material and methods ‐ Historical... To study fracture rates and risk factors for fractures in non-institutionalized patients with epilepsy. Historical follow-up. Self-administered questionnaires... To study fracture rates and risk factors for fractures in non-institutionalized patients with epilepsy.OBJECTIVESTo study fracture rates and risk factors for... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 269 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over Anticonvulsants - therapeutic use Biological and medical sciences Biomechanical Phenomena epilepsy Epilepsy - complications Epilepsy - drug therapy Female fracture Fractures, Bone - epidemiology Fractures, Bone - etiology Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Incidence Male Medical sciences Middle Aged Nervous system (semeiology, syndromes) Neurology Phenytoin - therapeutic use phenytoin. risk Risk Factors seizures |
Title | Fracture risk is increased in epilepsy |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1600-0404.1999.tb00675.x https://www.ncbi.nlm.nih.gov/pubmed/10348155 https://www.proquest.com/docview/69786437 |
Volume | 99 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB5CDiVQ-n44aVofSm9eVtb7GJIsodAcQgK5CT3GENo6S7wLbX59NLZ3my0ttKU3X8ayRvqkb6yZTwDvUWY0M5MqbJipBAu6sobnwDXEWkZPYjq92uepOrkQHy_l5VgeTbUwgz7E-ocbIaNfrwngPnSbIFdUFS2mgkrubP-PM9PfCTFKxhUJ6R-drbWkGEnhDVyYVYozMSqQjmk9v3nVxm71cO677LhmuPHiV5R0k-H2W9TsMXxddW7ITPk8WS7CJN7-pPv4v3r_BB6NXLY8GCbfU9jC9hk8-DSe1j-HDzMqwVreYEkJ7OVVV161RFI7TPmpxHlued59fwEXs-Pzw5NqvJehipxEC5AFZDoYZbn10cpG1wmbJBqVDMnFiFrHDHNvbZJaK29QGYmhMdgoL1PiL2G7vW7xNZRTraLmKYdpiosk8_oSMSUjQkSv47QuwK787-IoWk53Z3xx94KX7AhHjnDkCDc6wn0rgK9t54N0xx9Z7W8M8w9TrfP6pQp4txp2l5FIxyu-xetl51QOyOkYtIBXw2y41yqVO0tZgO7H9C8-xx2cHtfK7v6z5R7sDEoTlKP5BrYXN0vczzxqEd72-LgDGh8Mrg |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swED8hJg0ktPE1yDYgD4i3VE3iz0e0UZVB-4BA4s1K7ItUMYWKtBLw18-XpIWiIY2Jt7xcbN_57N_Zdz8DHCL33hwrF2ERq4jFuYy0Sn3gmtuE24zIdGq2z6HoX7Ff1_x6CQazWpiGH2J-4EaeUa_X5OB0IL3o5YLKolmXUc2drg85Pf7teEj5gXnkQbHYz4s5m1RMZHgNGo4jkcas5SBtE3te-dfCfrU2ziqvuqJ58-JvoHQR49abVO8zlLPhNbkpN53pJO_YxxfMj-82_nX41MLZ8LiZfxuwhOUmfBy0F_ZbcNSjKqzpHYaUwx6OqnBUEk6t0PmvEMe-6XH1sA1XvZPLH_2ofZohsinxFmCcYyxzJXSqM6t5IROHhWOFcIoYY1girff0TGvHpRSZQqE45oXCQmTcufQLLJe3Je5C2JXCytT5SE2kzHG_xFh0TrHcYiZtNwlAzwxgbMtbTs9n_DbP4hevCEOKMKQI0yrC3AeQzmXHDXvHP0ntLdj5SVRKv4SJAA5mdjfeGemGJSvxdloZ4WNyugkNYKeZDs9apYpnzgOQtVHf0B1zPDxJhP7635IHsNK_HJyb89Ph2TdYbYgnKGXzOyxP7qa452HVJN-vneUPAA8QzQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS9xAEB9EQQTR1o82ttY8iG85Lsl-PkrrYf04RBR8W5LdCYhtDOYO1L_enSR39UoLKr7lZbLZ2f3t_iY781uAXeQezbFyERaxilicy0ir1AeuuU24zUhMp1H7HIrDS3Z0xa-68miqhWn1IaY_3AgZzXpNAK9cMQtyQVXRrM-o5E43_zg9_e15RrnAhKcWRJHOp2JSMWnhtWQ4jkQas06CtMvr-c-7Zrar5SqrveeK9sqLf3HSWYrb7FGDVfg96V2bmnLTG4_ynn38S_jxvbr_AVY6Mhvut7PvI8xhuQaLp91x_TrsDagGa3yHIWWwh9d1eF0SS63R-acQK99yVT9swOXg4OL7YdRdzBDZlFQLMM4xlrkSOtWZ1byQicPCsUI4RXoxLJHW4zzT2nEpRaZQKI55obAQGXcu3YT58rbEzxD2pbAydT5OEylz3C8wFp1TLLeYSdtPAtAT_xvbqZbT5Rm_zLPoxTvCkCMMOcJ0jjD3AaRT26rV7niR1fbMMP8xldIvYCKAncmwGw9FOl_JSrwd10b4iJzOQQP41M6GZ61SvTPnAchmTF_xOWZ_eJAIvfVmyx1YPPsxMCc_h8dfYKlVnaB8za8wP7ob47bnVKP8WwOVJ60HD3w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fracture+risk+is+increased+in+epilepsy&rft.jtitle=Acta+neurologica+Scandinavica&rft.au=Vestergaard%2C+P.&rft.au=Tigaran%2C+S.&rft.au=Rejnmark%2C+L.&rft.au=Tigaran%2C+C.&rft.date=1999-05-01&rft.issn=0001-6314&rft.eissn=1600-0404&rft.volume=99&rft.issue=5&rft.spage=269&rft.epage=275&rft_id=info:doi/10.1111%2Fj.1600-0404.1999.tb00675.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1600_0404_1999_tb00675_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-6314&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-6314&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-6314&client=summon |